ABBV vs TMO
By Alex · Tickerpine
AbbVie Inc. vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | TMO |
|---|---|---|
| Price | $265.79 | $628.15 |
| Market cap | $469.68B | $232.26B |
| P/E ratio | 74.7 | 33.8 |
| ROE | — | 13.51% |
| Profit margin | 9.80% | 15.04% |
| Revenue growth | 10.20% | 10.50% |
| Dividend yield | 2.62% | 0.30% |
| Beta | 0.28 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs TMO in plain English
- ABBV is the bigger company — about 2.0× the market cap of TMO.
- TMO is cheaper on earnings (P/E 33.8 vs 74.7).
- TMO is growing revenue faster (10% vs 10%).
- ABBV has the higher dividend yield (2.62% vs 0.30%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.